IP Library Granted Patent US 8,222,016
Granted Patent B2
US 8,222,016 · App. 12/666,032 · Granted Jul 17, 2012

Recombinant C-terminal α-amidating enzyme derivative

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,222,016
App. No.
12/666,032
Granted
Jul 17, 2012
Kind
B2
Abstract

Disclosed are: a recombinant C-terminal α-amidated enzyme derivative which lacks the formation of at least one disulfide bond among five disulfide bonds occurring in a C-terminal α-amidated enzyme derived from Xenopus laevis ; DNA encoding the derivative; an expression vector carrying the DNA; a bacterium Escherichia coli transformed with the expression vector; and a method for producing the derivative by using the bacterium Escherichia coli.

Claims (8)

1. A recombinant enzyme comprising:

a polypeptide having an amino acid sequence set forth in SEQ ID NO: 2 wherein at least one cysteine residue at positions 6, 145, 40, 85, 252, or 274 is substituted to a non-cysteine amino acid, and

wherein said recombinant enzyme has α-amidating activity and lacks at least one disulfide bond between positions 6 and 145, positions 40 and 85, or positions 252 and 274.

2. A recombinant enzyme comprising:

a polypeptide having an amino acid sequence set forth in SEQ ID NO: 2 wherein at least one cysteine residue at positions 6, 145, 40, 85, 252, or 274 is substituted to a non-cysteine amino acid, and

wherein said recombinant enzyme has α-amidating activity and lacks at least one disulfide bond between positions 6 and 145, positions 40 and 85, or positions 252 and 274; and

wherein said non-cysteine amino acid is alanine.

3. The recombinant enzyme of claim 2 , wherein said enzyme is AE-I [1-321] (C40A and C85A) (SEQ ID NO: 27), AE-I [1-321] (C252A and C274A) (SEQ ID NO: 33), AE-I [1-321] (C40A and C85A, C252A and C274A) (SEQ ID NO: 37), AE-I [8-321] (C145A) (SEQ ID NO: 25), or AE-I [8-321] (C145A, C40A, and C85A) (SEQ ID NO: 35).

Assignments (2)
MERGER Recorded Aug 18, 2010
From: ASUBIO PHARMA CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 024851/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2009
From: OKUMURA, TAKESHI; FURUKAWA, KAZUAKI; YABUTA, MASAYUKI
To: ASUBIO PHARMA CO., LTD
Reel/Frame 023688/0503 →